Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

A phase I study of immunization using particle-mediated epidermal delivery of genes for gp100 and GM-CSF into uninvolved skin of melanoma patients.

Cassaday RD, Sondel PM, King DM, Macklin MD, Gan J, Warner TF, Zuleger CL, Bridges AJ, Schalch HG, Kim KM, Hank JA, Mahvi DM, Albertini MR.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):540-9.

2.

Relative Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor, Dacarbazine, and Glycoprotein 100 in Metastatic Melanoma: An Indirect Treatment Comparison.

Quinn C, Ma Q, Kudlac A, Palmer S, Barber B, Zhao Z.

Adv Ther. 2017 Feb;34(2):495-512. doi: 10.1007/s12325-016-0464-9. Epub 2016 Dec 20. Review.

3.

Systematic review of the use of granulocyte-macrophage colony-stimulating factor in patients with advanced melanoma.

Hoeller C, Michielin O, Ascierto PA, Szabo Z, Blank CU.

Cancer Immunol Immunother. 2016 Sep;65(9):1015-34. doi: 10.1007/s00262-016-1860-3. Epub 2016 Jul 2. Review.

4.

Clinical implications of the new biology in the development of melanoma vaccines.

Hemmila MR, Chang AE.

J Surg Oncol. 1999 Apr;70(4):263-74. Review.

Supplemental Content

Support Center